Medtech company commercializing a revolutionary cardiac assist device: biventricular and without blood-contact
AdjuCor has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in February 2023.
AdjuCor's investors include European Innovation Council and SMEs Executive Agency.
AdjuCor is headquartered in Munich, Germany.
Medtech company commercializing a revolutionary cardiac assist device: biventricular and without blood-contact
AdjuCor is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AdjuCor — Funding & Investors." VCBacked, February 3, 2023, https://www.vcbacked.co/company/adjucor. Accessed September 3, 2026.
VCBacked. (2023). AdjuCor — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/adjucor
{{cite web |title=AdjuCor — Funding & Investors |url=https://www.vcbacked.co/company/adjucor |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated